A
Angela Timoney
Researcher at Strathclyde Institute of Pharmacy and Biomedical Sciences
Publications - 15
Citations - 566
Angela Timoney is an academic researcher from Strathclyde Institute of Pharmacy and Biomedical Sciences. The author has contributed to research in topics: Health care & Sustainability. The author has an hindex of 9, co-authored 14 publications receiving 403 citations. Previous affiliations of Angela Timoney include NHS Lothian.
Papers
More filters
Journal ArticleDOI
Are new models needed to optimize the utilization of new medicines to sustain healthcare systems
Brian Godman,Rickard E. Malmström,Eduardo Diogene,Andy Gray,Sisira Jayathissa,Angela Timoney,Francisco de Assis Acurcio,Ali Alkan,Anna Brzezinska,Anna Bucsics,Stephen Campbell,Jadwiga Czeczot,Winnie de Bruyn,Irene Eriksson,Faridah Yusof,Alexander E. Finlayson,Jurij Fürst,Kristina Garuoliene,Augusto Afonso Guerra Junior,Jolanta Gulbinovič,Saira Jan,Roberta Joppi,Marija Kalaba,Einar Magnisson,Laura McCullagh,Kaisa Miikkulainen,Gabriela Ofierska-Sujkowska,Hanne Bak Pedersen,Gisbert Selke,Catherine Sermet,Susan Spillane,Azuwana Supian,Ilse Truter,Vera Vlahović-Palčevski,Low Ee Vien,Elif Hilal Vural,Janet Wale,Magdalene Wladysiuk,Wenjie Zeng,Lars L. Gustafsson +39 more
TL;DR: The objective is to review case histories among health authorities to improve the utilization and expenditure on new medicines, as well as develop exemplar models for valuing medicines for orphan diseases alongside potentially capping pharmaceutical expenditure.
Journal ArticleDOI
Barriers for Access to New Medicines: Searching for the Balance Between Rising Costs and Limited Budgets.
Brian Godman,Anna Bucsics,Patricia Vella Bonanno,Wija Oortwijn,Wija Oortwijn,Celia C. Rothe,Alessandra Ferrario,Simone Bosselli,Andrew Hill,Antony P. Martin,Steven Simoens,Amanj Kurdi,Amanj Kurdi,Mohamed Gad,Jolanta Gulbinovič,Angela Timoney,Angela Timoney,Tomasz Bochenek,Ahmed Salem,Iris Hoxha,Robert Sauermann,Amos Massele,Augusto Alfonso Guerra,Guenka Petrova,Zornitsa Mitkova,Gnosia Achniotou,Ott Laius,Catherine Sermet,Gisbert Selke,Vasileios Kourafalos,John Yfantopoulos,Einar Magnusson,Roberta Joppi,Margaret Oluka,Hye Young Kwon,Arianit Jakupi,Francis Kalemeera,Joseph O Fadare,Øyvind Melien,Maciej Pomorski,Magdalene Wladysiuk,Vanda Marković-Peković,Vanda Marković-Peković,Ileana Mardare,Dmitry Meshkov,Tanja Novakovic,Jurij Fürst,D Tomek,Corrine Zara,Eduardo Diogene,Johanna C Meyer,Rickard E. Malmström,Björn Wettermark,Björn Wettermark,Zinhle Matsebula,Stephen Campbell,Alan Haycox +56 more
TL;DR: The primary aim of this paper is to consider potential ways to optimize the use of new medicines balancing rising costs with increasing budgetary pressures to stimulate debate especially from a payer perspective.
Journal ArticleDOI
Review of Ongoing Activities and Challenges to Improve the Care of Patients With Type 2 Diabetes Across Africa and the Implications for the Future
Brian Godman,Debashis Basu,Yogan Pillay,Julius Chacha Mwita,Godfrey Mutashambara Rwegerera,Bene D. Anand Paramadhas,Celda Tiroyakgosi,Patrick Mbah Okwen,Loveline Lum Niba,Justice Nonvignon,Israel Abebrese Sefah,Margaret Oluka,Anastasia N. Guantai,Dan Kibuule,Francis Kalemeera,Mwangana Mubita,Joseph O Fadare,Olayinka O Ogunleye,Larry A. Distiller,Enos M Rampamba,J. R. Wing,Debjani Mueller,Abubakr A. Alfadl,Adefolarin A Amu,Zinhle Matsebula,Aubrey Chichonyi Kalungia,Trust Zaranyika,Nyasha Masuka,Janney Wale,Ruaraidh Hill,Amanj Kurdi,Amanj Kurdi,Angela Timoney,Angela Timoney,Stephen Campbell,Stephen Campbell,Johanna C Meyer +36 more
TL;DR: There are a number of ongoing activities across Africa to improve the management of patients with diabetes including co-morbidities, however, more needs to be done considering the high and growing burden of T2DM in Africa.
Journal ArticleDOI
Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implications
Brian Godman,Andrew Hill,Steven Simoens,Gisbert Selke,Iva Selke Krulichová,Carolina Zampirolli Dias,Antony P. Martin,Wija Oortwijn,Angela Timoney,Lars L. Gustafsson,Luka Voncina,Hye-Young Kwon,Jolanta Gulbinovič,Dzintars Gotham,Janet Wale,Wania Cristina Silva,Tomasz Bochenek,Eleonora Allocati,Amanj Kurdi,Olayinka O Ogunleye,Johanna C Meyer,Iris Hoxha,Admir Malaj,Christian Hierländer,Robert Sauermann,Wouter Hamelinck,Guenka Petrova,Ott Laius,Irene Langner,John Yfantopoulos,Roberta Joppi,Arianit Jakupi,Ieva Greiciute-Kuprijanov,Patricia Vella Bonanno,Jf Hans Piepenbrink,Vincent de Valk,Magdalene Wladysiuk,Vanda Marković-Peković,Ileana Mardare,Jurij Fürst,D Tomek,Merce Obach Cortadellas,Corinne Zara,Caridad Pontes,Stuart McTaggart,Tracey-Lea Laba,Øyvind Melien,Durhane Wong-Rieger,Seung Jin Bae,Ruaraidh Hill +49 more
TL;DR: In this paper, a number of potential pricing approaches are discussed including minimum effectiveness levels for new cancer medicines, managed entry agreements, multicriteria decision analyses (MCDAs), differential/tiered pricing, fair pricing models, amortization models as well as de-linkage models.
Journal ArticleDOI
Improving the managed introduction of new medicines: sharing experiences to aid authorities across Europe
Wojciech Matusewicz,Brian Godman,Hanne Bak Pedersen,Jurij Fürst,Jolanta Gulbinovič,Asbjørn Mack,Gisbert Selke,Angela Timoney,Ewa Warmińska,Rickard E. Malmström +9 more
TL;DR: The 3-day course on the managed introduction of new drugs was organised by the Piperska group together with the Agency for Health Technology Assessment and Tariff System (AOTMiT) and WHO Europe to share experiences and case histories.